BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 32878536)

  • 1. Radiographic analysis of fatty infiltration of the extraocular muscles in thyroid eye disease.
    Cohen LM; Liou VD; Cunnane ME; Yoon MK
    Orbit; 2022 Feb; 41(1):53-58. PubMed ID: 32878536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imaging of the medial rectus muscle predicts the development of optic neuropathy in thyroid eye disease.
    Berger M; Matlach J; Pitz S; Berres M; Axmacher F; Kahaly GJ; Brockmann MA; Müller-Eschner M
    Sci Rep; 2022 Apr; 12(1):6259. PubMed ID: 35428798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Visual field and orbital computed tomography correlation in dysthyroid optic neuropathy due to thyroid eye disease.
    Starks VS; Reinshagen KL; Lee NG; Freitag SK
    Orbit; 2020 Apr; 39(2):77-83. PubMed ID: 31057005
    [No Abstract]   [Full Text] [Related]  

  • 4. Occult thyroid eye disease in patients with unexplained ocular misalignment identified by standardized orbital echography.
    Volpe NJ; Sbarbaro JA; Gendron Livingston K; Galetta SL; Liu GT; Balcer LJ
    Am J Ophthalmol; 2006 Jul; 142(1):75-81. PubMed ID: 16815253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Superior oblique enlargement in thyroid eye disease.
    Del Porto L; Hinds AM; Raoof N; Barras C; Davagnanam I; Hancox J; Adams G
    J AAPOS; 2019 Oct; 23(5):252.e1-252.e4. PubMed ID: 31344455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiologic Parameters of Orbital Bone Remodeling in Thyroid Eye Disease.
    Tan NYQ; Leong YY; Lang SS; Htoon ZM; Young SM; Sundar G
    Invest Ophthalmol Vis Sci; 2017 May; 58(5):2527-2533. PubMed ID: 28492870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Asymmetric proptosis in thyroid eye disease.
    Rana K; Garg D; Yong LSS; Leyden J; Patel S; Slattery J; Davis G; Chan WO; Selva D
    Int Ophthalmol; 2024 Apr; 44(1):206. PubMed ID: 38678129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thyroid eye disease presenting with superior rectus/levator complex enlargement.
    Wang Y; Mettu P; Broadbent T; Radke P; Firl K; Shepherd JB; Couch SM; Nguyen A; Henderson AD; McCulley T; McClelland CM; Mokhtarzadeh A; Lee MS; Garrity JA; Harrison AR
    Orbit; 2020 Feb; 39(1):5-12. PubMed ID: 31056988
    [No Abstract]   [Full Text] [Related]  

  • 9. Correlation between extraocular muscle enlargement and thyroid autoantibodies in thyroid eye disease.
    Koizumi T; Tanaka T; Umeda K; Komiyama D; Obata H
    Jpn J Ophthalmol; 2024 May; 68(3):250-258. PubMed ID: 38609717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical Analysis of 2 170 Cases of Thyroid-Associated Ophthalmopathy Involving Extraocular Muscles].
    Yang M; Du BX; Wang YJ; He WM
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2021 May; 52(3):510-515. PubMed ID: 34018373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation between extraocular muscle size and motility restriction in thyroid eye disease.
    Dagi LR; Zoumalan CI; Konrad H; Trokel SL; Kazim M
    Ophthalmic Plast Reconstr Surg; 2011; 27(2):102-10. PubMed ID: 21383547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Teprotumumab reduces extraocular muscle and orbital fat volume in thyroid eye disease.
    Jain AP; Gellada N; Ugradar S; Kumar A; Kahaly G; Douglas R
    Br J Ophthalmol; 2022 Feb; 106(2):165-171. PubMed ID: 33172865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative CT of the orbit in Graves' disease.
    Ozgen A; Alp MN; Ariyürek M; Tütüncü NB; Can I; Günalp I
    Br J Radiol; 1999 Aug; 72(860):757-62. PubMed ID: 10624341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of Periorbital Soft Tissue in Thyroid Eye Disease.
    Mimura M; Yang PT; Ko AC; Korn BS; Kikkawa DO
    Ophthalmic Plast Reconstr Surg; 2020; 36(1):30-33. PubMed ID: 31567914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Absent Bell's phenomenon in patients with thyroid eye disease.
    Chung HW; Lee H; Baek S
    BMC Ophthalmol; 2021 Oct; 21(1):361. PubMed ID: 34635084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bilateral inferior oblique enlargement in thyroid eye disease.
    Vahdani K; Rose GE
    J AAPOS; 2021 Apr; 25(2):112-113. PubMed ID: 33338584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Whole-orbit-based multiparametric assessment of disease activity of thyroid eye disease on Dixon MRI.
    Xia D; Zhang H; Wang H; Jiang M; Tang Y; Li Y; Sun J; Song X; Zhou H
    Int Ophthalmol; 2024 May; 44(1):213. PubMed ID: 38700596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deep-Learning Based Automated Segmentation and Quantitative Volumetric Analysis of Orbital Muscle and Fat for Diagnosis of Thyroid Eye Disease.
    Alkhadrawi AM; Lin LY; Langarica SA; Kim K; Ha SK; Lee NG; Do S
    Invest Ophthalmol Vis Sci; 2024 May; 65(5):6. PubMed ID: 38696188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of lacrimal gland and extraocular muscle in thyroid eye disease patients with severe subjective dry eye disease: a multiparametric magnetic resonance imaging study.
    Liao X; Aljufairi FMAA; Sebastian JU; Jia R; Wong HYM; Lai KKH; Chen W; Hu Z; Wei Y; Chu WCW; Tham CCY; Pang CP; Chong KKL
    Graefes Arch Clin Exp Ophthalmol; 2024 Mar; ():. PubMed ID: 38456927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of orbital soft tissue biomechanical parameters in patients with thyroid eye disease using the non-contact Corvis ST.
    Moeen Rad A; Zarei-Ghanavati S; Sabermoghaddam A; Ghavami Shahri SH; Bakhtiari E; Kiarudi MY
    Int Ophthalmol; 2023 Oct; 43(10):3615-3621. PubMed ID: 37393605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.